跳至主要内容
临床试验/ACTRN12605000258651
ACTRN12605000258651已完成3 期

The antioxidant and immunomodulatory effects of Ambrotose AO in healthy smokers and non-smokers

Mannatech0 个研究点目标入组 20 人开始时间: 2005年9月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
Mannatech
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
All

入选标准

  • 1. Individuals willing to cease all medications over the course of the study, excluding medications for acute conditions such as pain or dyspepsia.

排除标准

  • 1. Individuals taking antioxidant medications and/or supplements2. Individuals with poor venous access3. Individuals with auto-immune disorders4. Individuals with diabetes5. Individuals taking immune suppressant drugs6. Individuals taking cytokine or interferon therapy7. Individuals taking Echinacea or other immune stimulating herbs8. Individuals with clinically abnormal liver function tests at baseline9. Individuals unwilling to have blood taken 9 times during the study10. Individuals unwilling to comply with the study protocols11. Individuals with any other condition which in the opinion of the researchers could compromise the study.

研究者

发起方
Mannatech

相似试验